| ■ 英語タイトル：Global Behcets Disease Market Size study & Forecast, by Treatment Type [Corticosteroids, Immunosuppressive Agents and Immunomodulators] and by Symptoms [Eyes, Bowels, Skin and Mucosa, Lungs, Brain, Bones, Blood Vessels and Heart) and Regional Analysis, 2022-2029
|
 | ■ 発行会社/調査会社：Bizwit Research & Consulting
■ 商品コード：BZW23MR029
■ 発行日：2023年2月27日
■ 調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野：医療
■ ページ数：約200
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
|
■ 販売価格オプション
（消費税別）
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。
| ★グローバルリサーチ資料[ベーチェット病のグローバル市場（2022年-2029年）：コルチコステロイド、免疫抑制剤＆免疫調節剤]についてメールでお問い合わせはこちら
|
*** レポート概要（サマリー）***Bizwit Research社の市場調査レポートは、2021年にXX億ドルであった世界のベーチェット病市場規模が、2022年から2029年の間にXX%成長すると推測しています。本書では、ベーチェット病の世界市場を広く調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、治療種類別（コルチコステロイド、免疫抑制剤＆免疫調節剤）分析、症状別（眼、腸、皮膚＆粘膜、肺、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他）分析、競争状況、調査プロセスなどについて以下の構成でまとめています。なお、参入企業情報として、Creabilis Limited、Cell Medica Limited、Actelion Ltd、Abbott Laboratories、Novartis AG、Les Laboratoires、Servier SAS、AbbVie Inc.、Celgene Corporation、F. Hoffmann La Roche Ltd.などが含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界のベーチェット病市場規模：治療種類別
- コルチコステロイドの市場規模
- 免疫抑制剤＆免疫調節剤の市場規模
・世界のベーチェット病市場規模：症状別
- 眼症状における市場規模
- 腸症状における市場規模
- 皮膚＆粘膜症状における市場規模
- 肺症状における市場規模
- その他症状における市場規模
・世界のベーチェット病市場規模：地域別
- 北米のベーチェット病市場規模
- ヨーロッパのベーチェット病市場規模
- アジア太平洋のベーチェット病市場規模
- 中南米のベーチェット病市場規模
- その他地域のベーチェット病市場規模
・競争状況
・調査プロセス |
Global Behcets Disease Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Behcets Disease or Behcet’s syndrome, is a rare disorder that causes blood vessel inflammation throughout the body. This is an autoinflammatory condition is where body’s natural defence against infection and illness – mistakenly attacks healthy tissue. The major symptoms of Behcets disease are genital and mouth ulcers, red, painful eyes and blurred vision, acne-like spots, headaches, painful, stiff, and swollen joints among others. The rise in incidences of Behcets disease worldwide and growing technological advancements in healthcare industry are key factor driving the market growth.
The increasing prevalence of Behcets disease is driving the global market growth. For instance – as per National Center for Biotechnology Information (NCBI) – as of December 2022, Turkey has the highest prevalence of Behcets disease affecting 420 people per 100,000 population. Additionally, In the United States, the prevalence is estimated at 5.2 people per 100,000 population. Moreover, Behcets UK’s estimates – in the United Kingdom the prevalence of Behcets disease is estimated at 0.64 people per 100,000 population. Also, increasing R&D expenditure in healthcare sector and growing prevalence of autoinflammatory conditions would create lucrative growth prospectus for the market over the forecast period. However, the lack of awareness towards Behcets Disease stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Behcets Disease Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific dominated the market in terms of revenue, owing to the high prevalence of Behcets disease and growing healthcare sector in the region. Whereas North America is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising incidents of Behcets diseases and presence of leading market players in the North American region.
Major market player included in this report are:
Creabilis Limited
Cell Medica Limited
Actelion Ltd
Abbott Laboratories
Novartis AG
Les Laboratoires
Servier SASAbbVie Inc.
Celgene Corporation
F. Hoffmann La Roche Ltd.
Recent Developments in the Market:
In July 2019, the U.S. Food and Drug Administration approved apremilast from Celgene Corporation for the treatment of oral ulcers associated with Behcet’s disease.
Global Behcets Disease Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Treatment Type, Symptoms, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment Type
Corticosteroids
Immunosuppressive Agents
Immunomodulators
By Symptoms
Eyes
Bowels
Skin and Mucosa
Lungs
Brain
Bones
Blood Vessels and Heart
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Behcets Disease Market, by Region, 2019-2029 (USD Billion)
1.2.2. Behcets Disease Market, by Treatment Type, 2019-2029 (USD Billion)
1.2.3. Behcets Disease Market, by Symptoms, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Behcets Disease Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Behcets Disease Market Dynamics
3.1. Behcets Disease Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. rise in incidences of Behcets disease worldwide
3.1.1.2. Growing technological advancements in healthcare industry
3.1.2. Market Challenges
3.1.2.1. Lack of awareness among individuals
3.1.3. Market Opportunities
3.1.3.1. Increasing R&D expenditure in healthcare sector
3.1.3.2. Growing prevalence of autoinflammatory conditions
Chapter 4. Global Behcets Disease Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Behcets Disease Market, by Treatment Type
6.1. Market Snapshot
6.2. Global Behcets Disease Market by Treatment Type, Performance – Potential Analysis
6.3. Global Behcets Disease Market Estimates & Forecasts by Treatment Type 2019-2029 (USD Billion)
6.4. Behcets Disease Market, Sub Segment Analysis
6.4.1. Corticosteroids
6.4.2. Immunosuppressive Agents
6.4.3. Immunomodulators
Chapter 7. Global Behcets Disease Market, by Symptoms
7.1. Market Snapshot
7.2. Global Behcets Disease Market by Symptoms, Performance – Potential Analysis
7.3. Global Behcets Disease Market Estimates & Forecasts by Symptoms 2019-2029 (USD Billion)
7.4. Behcets Disease Market, Sub Segment Analysis
7.4.1. Eyes
7.4.2. Bowels
7.4.3. Skin and Mucosa
7.4.4. Lungs
7.4.5. Brain
7.4.6. Bones
7.4.7. Blood vessels and Heart
Chapter 8. Global Behcets Disease Market, Regional Analysis
8.1. Behcets Disease Market, Regional Market Snapshot
8.2. North America Behcets Disease Market
8.2.1. U.S. Behcets Disease Market
8.2.1.1. Treatment Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Symptoms breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Behcets Disease Market
8.3. Europe Behcets Disease Market Snapshot
8.3.1. U.K. Behcets Disease Market
8.3.2. Germany Behcets Disease Market
8.3.3. France Behcets Disease Market
8.3.4. Spain Behcets Disease Market
8.3.5. Italy Behcets Disease Market
8.3.6. Rest of Europe Behcets Disease Market
8.4. Asia-Pacific Behcets Disease Market Snapshot
8.4.1. China Behcets Disease Market
8.4.2. India Behcets Disease Market
8.4.3. Japan Behcets Disease Market
8.4.4. Australia Behcets Disease Market
8.4.5. South Korea Behcets Disease Market
8.4.6. Rest of Asia Pacific Behcets Disease Market
8.5. Latin America Behcets Disease Market Snapshot
8.5.1. Brazil Behcets Disease Market
8.5.2. Mexico Behcets Disease Market
8.5.3. Rest of Latin America Behcets Disease Market
8.6. Rest of The World Behcets Disease Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Creabilis Limited
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Cell Medica Limited
9.2.3. Actelion Ltd
9.2.4. Abbott Laboratories
9.2.5. Novartis AG
9.2.6. Les Laboratoires
9.2.7. Servier SAS
9.2.8. AbbVie Inc.
9.2.9. Celgene Corporation
9.2.10. F. Hoffmann La Roche Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
*** 免責事項 ***https://www.globalresearch.co.jp/disclaimer/
